Evidence-Based Guideline on Management of Postoperative Delirium in Older People for Low Resource Setting: Systematic Review Article.

Background: Postoperative delirium is the highest prevalence and life-threatening complication following geriatric surgery. The overall incidence rate varies from 5% to 52% of hospitalized surgical patients based on the type of surgery that often began in the postanesthesia care unit and continues up to 5 days post-surgery. Postoperative delirium manifests as a hypoactive, hyperactive and mixed subtype. The mechanism of delirium development is not clear, but it is accepted that delirium is a result of the patient's underlying vulnerabilities or risk factors combined with an outside stressor such as infection or surgery. Objective: To develop evidence-based recommendations for the prevention, diagnosis, and treatment of postoperative delirium.
Methods: Literature was searched from PubMed, CINAH, Google Scholar, and Cochrane databases that are published from 2010 to 2021 by formulating inclusion and exclusion criteria. Filtering was made depending on methodological quality, outcome, and data on population. Finally, 11 meta-analysis, 11 systematic reviews, 7 interventional studies, 11 observational studies, and recommendations of the previous clinical practice guideline developed by the American and European are included in this review.
Results: A total of 43 studies were considered in this evaluation. The development of this guideline was based on nine studies on risk stratification for postoperative delirium, eighteen studies on risk minimization and prevention for postoperative delirium, five studies on diagnosis for postoperative delirium, and eleven studies on treatments for postoperative delirium.
Conclusion: Postoperative delirium management can be categorized into risk assessment, risk minimization, early diagnosis, and treatment. Early diagnosis is critical to trigger focused and effective treatment. Non-pharmacological interventions are the first-line management for both hypoactive and hyperactive postoperative with considering contributory factors and underlying causes. Antipsychotics should only be used for hyperactive delirium individuals who try to harm themselves. Current evidence suggested that dexmedetomidine can be used as a treatment option for postoperative delirium.

Introduction

Background

Delirium is defined as disturbances of mental abilities that affect thinking perception, memory, emotion, and sleep-wake disturbance. Based on the American Psychiatric Association (DSM V), a delirium diagnosis can be made when a patient presents with disorganized thinking, disturbance in attention, and level of consciousness which develops over a short period and fluctuates over time.1,2

Postoperative delirium (POD) refers to delirium in patients after completion of a surgical procedure and is defined as an acute mental disorder, characterized by disturbances in awareness, attention, and cognition. As a common postoperative complication, all age groups of patients can affect by this complication, but this postoperative complication is highly affected geriatric patients, with an incidence rate ranging from 5% to 52% depending on the risk to patients and surgical procedure of an elderly population which often began in the post-anesthesia care unit and continuous up to 5 days post-surgical procedure.3,4

Surgeries strongly associated with delirium include vascular, orthopedic, and cardiac surgery, with the condition occurring in up to 50% of the patient’s postoperative. Postoperative delirium is highly associated with emergency surgery, which is an account for 1.5 to three times non-emergency surgical procedure.5

A review by Abate et al found that the global prevalence of POD among geriatric surgical patients was 20% with the highest in patients who undergo general surgery followed by orthopedics and malignant surgeries, 23%, 22%, and, 19%, respectively.6

POD can manifest as hypoactive (drowsy, reduced motor activity), hyperactive (agitation, aggressive behavior, restlessness and harm to themselves or another individual) and mixed delirium which is characterized by showing both delirium symptoms. Hypoactive delirium is the commonest type present in around 40% of delirium cases and is unrecognized. Hypoactive delirium prognosis may be worse, secondary to under-detection by health professionals and delayed response to treatment.7 Based on the onset time, delirium in the postoperative period can be divided into emergence delirium (ED) and POD. Emergence delirium happens lasting approximately 30 minutes after emergent from surgical anesthesia procedure. Whereas POD is often notable from postoperative day 1 to a week after surgery.8

Adverse outcomes of POD include 2–3 days increase hospital stay, minimized mental activity, risk of dementia increment, and increase dependency. Furthermore, delayed recognition and treatment are related to 30-day mortality of 7% to 10% and overall mortality was up to 25%.6,9–11

The most common complication of geriatric surgery is POD with an overall incidence rate of 5% to 52% of the geriatric surgical patient.3,4,10 According to a recent review study, the prevalence of mortality from patients with POD was 25%.12 This indicates that POD has a huge burden on the health-care system and the patients.

Management of postoperative delirium can be categorized into risk assessment and stratification, risk reduction, early diagnosis, and treatment. Up to forty percent of POD can be preventable and the most effective management of POD is prevention.10,11

Identifying patients at the highest risk of developing delirium is a necessary first step, risk reduction technique by the non-pharmacological and pharmacological second step, early diagnosis is critical to trigger focused and effective treatment is an important technique in the management of postoperative delirium.13

Previous published clinical practice guidelines recommend the Confusion assessment method (CAM) and Nursing Delirium Screening Scale (Nu-DESC) as gold standards for the detection of POD, but recent evidence suggests that both screening tools have low sensitivity and specificity when compared to the 4ʹA’s Test, which has high sensitivity and specificity, requires no time or special training, and is useful in resource-limited areas.14

Furthermore, when nonpharmacological approaches have failed to control severe agitation, low-dose antipsychotics are indicated, and now, non-antipsychotic drugs such as dexmedetomidine are suggested as an alternative therapeutic agent for POD, which is included in the current guideline.15 Physicians, anesthetists, and nurses are the most common clinicians involved in the care of POD patients. Since there are different health personnel they are doing it in different ways. As a result, the purpose of these guidelines is to give guidance for clinical practice in the prevention, diagnosis, and treatment of POD. The main research questions for this systematic review are whether there are risk stratifications for POD, the use of pharmacologic and non-pharmacologic strategies for prevention of POD, identification of a quick and easy assessment tool, and determining evidence-based recommendations for the treatments of POD in old people.

Methodology

The review was conveyed based on preferred reporting items for systematic review and meta-analysis (PRISMA) protocol. Literature was searched from PubMed, Google Scholar, CINAHL, and Cochrane database in the last ten years from 2010 to 2021 to specify studies that are relevant to do this clinical practice guideline using the keywords postoperative delirium, delirium prevention, delirium screening, elderly people, and delirium treatment. From a lot of evidence obtained from a search engine, the repetition was removed using the EndNote reference manager. Studies assessing the postoperative delirium in older people management that investigating the delirium risk stratification, risk reduction, diagnosis, treatment which were published in the English language were included in the review. Articles with a pediatric patient population, not a clinical study post operative delirium based, poor methodological quality, and studies written other than the English language were excluded. Based on Critical Appraisal articles were appraised and graded depending on their level of evidence. Systematic reviews were appraised and graded according to the AMSTAR-2 appraisal checklist.16 Randomized controlled trials and prospective or retrospective cohort studies were also appraised according to the appraisal checklist of the critical appraisal skill program tool (CASP).17 Finally, 11 Meta-analyses, 11 systematic reviews, 7 RCT, 11 observational studies, and 3 recommendations of previous clinical practice guidelines by the American and European were used for this review (see Figure 1) by using the keywords (Risk assessment AND postoperative delirium, Risk-reducing AND postoperative delirium, early diagnosis AND postoperative delirium and, postoperative delirium AND Management). Two evaluators independently reviewed and determined the eligibility of articles based on the methodological quality of inclusion and exclusion criteria, as well as outcome variables. The third assessor evened out any discrepancies. The conclusion was reached using the degree of evidence provided by the Oxford Center for Evidence-Based Medicine (Table 1).18

Figure 1

PRISMA flowchart adapted from Liberati A, Altman D, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology. 2009.

Table 1

Levels of Evidence and Grades of Recommendations

Level of Evidence	Grading Criteria	Degree of Recommendation
1a	Systematic reviews and meta-analysis of RCTs including the Cochrane systematic review	A
1b	Individual RCT with a narrow confidence interval	A
1c	All or none randomized controlled trials	B
2a	A systematic review of cohort studies	B
2b	Individual cohort study (including low-quality RCT; eg, <80% follow-up)	B
2c	‘Outcomes’ research; ecological studies	C
3a	A systematic review of Case-control studies	C
3b	Individual case-control study	C
4	Ca series, poor quality cohort, and case-control studies	C
5	Expert opinion without explicit critical appraisal	D

Abbreviation: RCT, randomized clinical trial.

Discussion

Postoperative delirium management can be divided into risk assessment, risk minimization, early diagnosis, and treatment. Up to forty percent of POD can be preventable and the most effective management of POD is prevention.10,11 Level 1a

Risk Assessment of Postoperative Delirium

Risk factors: risk identification is an important step in the prevention and management of POD. Many risk factors are associated with postoperative delirium like age, type of surgical procedure, substance abuse, premedication with diazepam, and so on. But also there is another risk factor for POD not only the mentioned condition.6,19 Level 1a

The risk factors are categorized into aggravating and predisposing conditions. The most common predisposing factors include advanced age, baseline cognitive impairment, ASA physical status ≥III, frailty, presence of multiple medical comorbidities, alcohol abuse or smoking, and sensory impairment. Aggravating factors are many drugs use, low nutritional status, poor pain management, catheter in place, blood loss, preoperative anemia, intraoperative hypotension, fluid/electrolyte disorders, duration of surgery, type of surgery.7,12,20 Level 1a

Gracie et al conducted a review that suggests the relationship b/n preoperative weakness and POD in patients undergoing surgery with the age of 65 and above with an odds ratio for POD in weakness vs non-weakness patients with an odds of 2.14.13 Level 1a

The Mini-Cog© Screening tool is used to categorize older clients at risk of POD. It is simple, free, and is effective in populations of varying ethnicity and educational level with adequate predictive power. Mini-Cog score of 4 has (PPV = 21% and NPV = 94%), score of 2 or worse has PPV 36% NPV & 90% and score of 0 or 1 has PPV 60% and NPV 88%((0–2 = high risk, 3–5 = low risk).21 Level 2b

At-risk patients: AGS stated that one or more of the following conditions are at risk for the patients for POD: 65 years and older age, any past or present cognitive dysfunction, present fracture of the hip, critically ill, and coexisting disease).10 Level 1a

High-risk patient: Any patient with a pre-existing diagnosis of delirium/dementia and/or Alzheimer’s disease. Any patient age 65 years or older that scores <2 on the Mini-Cog© preoperative screening tool.22 Level 2a

Risk-Reducing Interventions

Multicomponent Nonpharmacological Management for the Prevention of Postoperative Delirium

Multidisciplinary activity in all health-care institutions regarding the nonpharmacological multicomponent approach for at-risk geriatric clients undergoing a surgical procedure to prevent postoperative delirium (strong recommendation: moderate quality of evidence).10 Level 1a

Preventing Increasing (>6 h) Fluid Fasting Time

According to NPO guidelines clear fluid takes 2 hours for gastric emptying, but clients are usually prolonged fasting in clinical practice. A study shows that greater than 6-hour fasting fluid is an independent risk factor for POD, with an OR of 10.57 confidence interval 1.4–78.6.23 Level 2b

Avoidance of Inappropriate Medications

American Geriatric Society recommends health-care professionals have to prevent drugs that induce POD in geriatrics to avoid delirium. Medications or medication classes associated with postoperative delirium include benzodiazepines, anticholinergics, histamine2-receptor antagonists, promethazine, tricyclic antidepressants, and meperidine (strongly recommended; low quality of evidence).10 Level 1a

Dexmedetomidine During General Anesthesia

Recent review by Qi-Hong Shen et al shows that postoperative delirium incidence was low in the dexmedetomidine group than in the control group with P-values of <0.01.24 Level 1a

Another review by Zeng et al revealed that dexmedetomidine highly decreases the prevalence of postoperative delirium when compared with a control group with a P-value of = 0.001). Even though, dexmedetomidine risk of decreasing heart rate with a P-value of = 0.003. Begin bolus of 1mcg/kg over 10 minutes before induction and then initiate infusion. Maintain infusion between 0.2–0.7 mcg/kg/hr throughout the entirety of the case unless contraindicated25,26 Level 1a, 2b. Many ways were expressed to state how dexmedetomidine decreases the incidence and prevalence of POD post-surgical procedure and anesthesia. These include reducing the number of sedatives and algesia used while surgical procedures, attenuating the immune cascade and inflammatory mediators, and dexmedetomidine making a natural sleep-like sedative stress, which might support to decrease the risk of postoperative delirium.27 Level 1a

Anesthetic Techniques

General or regional anesthesia: A systematic study by Patel et al in 2018 showed that there was no difference between the type of anesthesia and POD28 Level 2a. However, another recent meta-analysis in 2021 by Abate et al POD was around 3 times in client surgery done with general anesthesia when compared to neuraxial anesthesia.6 Level 1a

Choice of general anesthetic: In cardiac surgery procedure Ketamine was minimized post-operative delirium prevalence if delivered preoperative period, an induction with 0.5mg/kg ketamine, also minimize the incidence of POD.29 Another multicenter RCT study by Avidan et al indicates there is no difference in POD prevalence b/n both ketamine and the placebo group. But postoperative hallucinations and nightmares were increased depending on ketamine doses increment with the placebo group.30 Level 1b. The study by Zhang et al suggested that inhalational anesthesia techniques can exacerbate the POD31 Level 2b. Nevertheless, other cohort studies do not show the incidence of postoperative delirium between inhalational and IV anesthesia techniques.32 Level 2b

Volatile agents or TIVA: Evidence from reviews of 28 randomized control trials show that type of anesthesia maintenance had no difference regarding the incidence of postoperative delirium evidence of a difference in incidences of POD, mortality of 30 days, and length of hospital stay. But some studies suggest that TIVA-based maintenance may decrease POD.33 Level 1a

Depth of anesthesia: Punjasawadwong et al found that Anesthesia administration guided by bispectral index may decrease the incidence of POD during the post-surgical procedure with RR of 0.7 1 in geriatric patients for the procedure of non‐neurosurgical and non‐cardiac surgical procedure34 Level 1a. Another systematic review also shows that BIS is related to a highly decreased risk of postoperative delirium and cognitive decrement with an OR of 0.51.35 Level 1a

Multimodal analgesia technique use: acute: Pain is the major issue during post-surgical procedures and a higher pain score assessment was increased postoperative delirium36 Level 2b. Publication by the USA Geriatrics Society and USA College of Surgeons recommends the use of regional anesthesia and multi-modal pain techniques as a way of minimizing opioid administration, as narcotics are associated with increases in delirium incidence (strong recommendation: moderate quality of evidence).12 Level 1a

Use of paracetamol and magnesium sulfate: It has been suggested that postoperative IV paracetamol had a decrease in postoperative delirium (10% vs 28%) placebo by directly alleviating neuroinflammation in geriatrics clients for cardiac surgery procedure37 Level 1b. In a recent clinical intraoperative administration of magnesium sulfate (30mg/kg and followed by 9mg/kg up to the completion of the surgery) reduce the incidence of postoperative agitation to 59% and 74% in the placebo group (P < 0.0001) in patients undergoing endoscopic sinus surgery.38 Level 1b

Regarding Diagnosis of Delirium

For postoperative delirium management, early diagnosis is very important. Since POD cannot be diagnosed by laboratory tests clinical and frequent observation is very important for the diagnosis of delirium.4,10 Level 1a

4AT test versus Nu-DESC: The study by Saller et shows that POD assessment of recovery with 4AT has highly sensitive and specific. 4AT sensitivity and specificity were 95.5% and 99.2%, respectively. However, Nu-DESC sensitivity and specificity were 27.3% and 99.4%, respectively. So 4AT was high sensitive than the Nu-DESC with a p-value <0.001.14 Level 2b

4AT versus CAM: Prospective diagnostic test accuracy study by Shenkin et al presented that the sensitivity and the specificity 4AT were 76% and 94% respectively. While the CAM sensitivity and specificity were 40% and 100%, respectively, and requires up to 10 min for the administrator, this study concluded that 4AT is a time-saving technique and is easily used in routine clinical activity.39 Level 2b

Another recent review by Tieges et al in 2020 also qualified the diagnostic accuracy of the 4AT with the sensitivity and specificity of 0.88 and 0.88, respectively. The 4 ‘A’s Test tool is important for postoperative delirium diagnosis with good sensitivity and brief do not need a unique technique, easy to use, and allows for the assessment of patients with drowsy and agitation condition.40 Level 1a

Postoperative Delirium Management

The first step in the management of POD is identifying and treating associated risk factors like acute pain, infection, fluid loss acid-base imbalance, and failure to urinate. The PINCH ME technique gives a clue to guide the treatment of delirium clients in the acute setting.41 Level 2a

P = pain

I = infection/intoxication

N = nutrition

C = constipation/urinary retention

H = hydration/hypoxia

M = medication

E = environmental risk factors

Non-Pharmacological Management of POD

In postoperative delirium prevention, management of POD technique requires a multidisciplinary approach regarding the non-pharmacological approach for prevention of preoperative risk factors for POD. Evidence from the Cochrane database of systematic reviews by Burton et al conclude that nonpharmacological interventions are effective for treatments of POD in the non-intensive unit care area. These strategies include reorientation, sleep enhancement, hearing and vision optimization by using hearing and vision aids, early mobilization, adequate hydration, infection prevention, pain management, and assessment.42 Level 1a

A clinical trial by Colombo R has shown that orientation can decrease the incidence of postoperative delirium by 40%. This activity may be performed by reducing changes in staff and clients transfer, periodic staff members introduction, nature of light assessment and maintaining of keeping time, the previous situation reminding regarding the previous issue, and planning for future events.43 Level 1b

Pharmacological Treatment

Currently, pharmacologically based managements of postoperative delirium options were limited, and their usage is considered depending on expected adverse effects. Drug-based treatment for POD does not consider for all clients and is used only for patients who do not respond to non-pharmacological treatments.27 Level 1a

Antipsychotics: Evidence of systematic reviews recently show that antipsychotic medication did not decrease the post-operative delirium severity, treat signs and symptoms of delirium, or did not change mortality. But adequate evidence was not concluded regarding antipsychotic drug treatment for postoperative delirium.44 Level 1a

AGS recommends patients with hyperactive delirium who show aggressive behavior and harm themself and other staff members as a second-line minimum dose of antipsychotic drugs was used to management of postoperative delirium (weak recommendation; low quality of evidence).10 Level 1a

Olanzapine VS Haloperidol for Managements of POD

The multicenter, Phase III RCT by van der Vorst et al, management of delirium by olanzapine and haloperidol show that there is no significant difference regarding the efficacy of the two drugs with P-value= 0.1845 Level 1b. Another systematic review by Schrijver EJ & de Graaf K found haloperidol and olanzapine were equally efficacious and well tolerated and can be safely used in the treatment of delirious patients, but the difference was not significant statistically (P = 0.765). Haloperidol is a highly selected drug since it is available in different formulations (oral, IM, and IV), it is affordable, and had a low risk of sedation and decreasing blood pressure complications but the risk of heart conduction problems was high. It mostly begins with low doses,4 hourly with a maximum dose of 3–5 mg daily for the elderly.46 Level 2a

Dexmedetomidine for Treatment of POD

Current evidence has suggested that dexmedetomidine is a promising agent, not only for prevention but also for the management of POD. A non RCT by Carrasco et al shows that an adequate stage of sedation was achieved by dexmedetomidine than haloperidol with the percentage of 92.7% and 59.3%, respectively, with a p-value = 0.0001. Infusion of 0.2 μg/kg/h titrated up to 0.7h μg/kg/h15 in non-intubated clients who did not respond to haloperidol treatments and it has good effectiveness and low cost. Level 1c

Benzodiazepines

Recent evidence from the Cochrane Database of Systematic Reviews by Li Y, Ma J, in 2020 does not recommend treatments of postoperative delirium with benzodiazepine because it increases the hypoactive delirium condition.47 Level 1a

A clinical practice guideline developed by AGS also recommends not using even these drugs for hyperactive delirium or agitated clients unless otherwise, the cause was secondary to alcohol withdrawal syndrome.10 Level 2b. An observation study by Levine et al conclude that there was no difference between Lorazepam and Diazepam for the management of alcohol withdrawal hyperactive delirium with a P- value = 0.534). Lorazepam was the same effect as diazepam for the treatment of alcohol withdrawal syndrome.48 Level 2b

A meta-analysis that was done by Wu et al found that a combination of haloperidol and lorazepam give the highest response rate with an odds ratio of 28.13 (CI 2.38–333.08) among Lorazepam OR 5.34 (CI0.28–101.95), Olanzapine OR 2.46 (CI 0.71–8.57), Haloperidol OR 2.37 (CI 1.04–5.43) and Dexmedetomidine OR 2.06 (CI 0.51–8.34) (Table 2).49 Level 1a

Table 2

The Result of the Studies Included in This Evidence-Based Guideline

S. No	Author	Study on Risk Stratification for Postoperative Delirium	Quality/Level
1	Couban R, et al	Preoperative prognostic factors associated with postoperative delirium in older people undergoing surgery: protocol for a systematic review and individual patient data meta-analysis. Systematic reviews. 2020;9(1):1–5.	1a
2	Aynalem AE, et al	Global Prevalence and predictors of postoperative delirium among non-cardiac surgical patients: a systematic review and Meta-analysis. International Journal of Surgery Open. 2021:100334.	1a
3	Wang DX, et al	Emergence delirium is associated with increased postoperative delirium in elderly: a prospective observational study. 2020;34(5):675–87.	2b
4	Ing C, et al.	Association of Delirium With Long-term Cognitive Decline: a Meta-analysis. JAMA Neurology. 2020;77(11):1373–81.	1a
5	Deiner SG, et al	Postoperative delirium: a review of risk factors and tools of prediction. Current Anesthesiology Reports. 2015;5(1):48–56.	1a
6	Sieber FE, et al	The Association of Preoperative Frailty and Postoperative Delirium: A Meta-analysis. Anesthesia & Analgesia. 2021:10.1213.	1a
7	Wang X, et al	Incidence and risk factors of postoperative delirium in elderly patients undergoing transurethral resection of prostate: a prospective cohort study. Neuropsychiatric disease and treatment. 2016;12:137.	2b
8	Goodlin SJ, et al	A Simple Tool to Predict Development of Delirium After Elective Surgery. J Am Geriatr Soc. 2016;64(11):e149-e53.	2b
9	Schenning KJ, et al	Preoperative cognitive and frailty screening in the geriatric surgical patient: a narrative review. Clinical therapeutics. 2015;37(12):2666–75.	1a
		Study on Risk minimization and prevention for postoperative delirium
10	Esnaola NF, et al	Optimal perioperative management of the geriatric patient: a best practices guideline from the American College of Surgeons NSQIP and the American Geriatrics Society. Journal of the American College of Surgeons. 2016;222(5):930–47.	1a
11	van der Laan L, et al	Prevention of postoperative delirium in elderly patients planned for elective surgery: systematic review and meta-analysis. Clinical interventions in aging. 2019;14:1095.	1a
12	Yuan Xz, et al.	Dexmedetomidine in the prevention of postoperative delirium in elderly patients following non‐cardiac surgery: a systematic review and meta‐analysis. Clinical and Experimental Pharmacology and Physiology. 2020;47(8):1333–41.	1a
13	He J, Fu W, et al	Dexmedetomidine for the prevention of postoperative delirium in elderly patients undergoing noncardiac surgery: a meta-analysis of randomized controlled trials. PLoS One. 2019;14(8):e0218088.	1b
14	Kang H, et al	Pharmacological strategies to prevent postoperative delirium: a systematic review and network meta-analysis. Anesthesia and pain medicine. 2021;16(1):28.	1a
15	Yeung J, et al	Effect of regional versus general anaesthesia on postoperative delirium in elderly patients undergoing surgery for hip fracture: a systematic review. BMJ open. 2018;8(12):e020757.	1a
16	Putensen C, et al	Postoperative delirium in the PACU and intensive care unit. Trends in Anaesthesia and Critical Care. 2012;2(4):148–55.	2c
17	Pryor KO, et al	Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial. The Lancet. 2017;390(10091):267–75.	1b
18	Xie Z, et al	Isoflurane and sevoflurane increase interleukin-6 levels through the nuclear factor-kappa B pathway in neuroglioma cells. British Journal of Anaesthesia. 2013;110:i82-i91.	2b
19	Pang J, et al	The influence of propofol or desflurane on postoperative cognitive dysfunction in patients undergoing coronary artery bypass surgery. Anaesthesia. 2011;66(6):455–64.	2b
20	Alderson P, et al	Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non‐cardiac surgery. Cochrane Database of Systematic Reviews. 2018(8).	1a
21	Pin‐on P, et al	Processed electroencephalogram and evoked potential techniques for amelioration of postoperative delirium and cognitive dysfunction following non‐cardiac and non‐neurosurgical procedures in adults. Cochrane Database of Systematic Reviews. 2018(5).	1a
22	Luo C, Zou W.	Cerebral monitoring of anaesthesia on reducing cognitive dysfunction and postoperative delirium: a systematic review. Journal of International Medical Research. 2018;46(10):4100–10.	1a
23	Goodspeed V, et al.	Effect of Intravenous Acetaminophen vs Placebo Combined With Propofol or Dexmedetomidine on Postoperative Delirium Among Older Patients Following Cardiac Surgery: the DEXACET Randomized Clinical Trial. JAMA. 2019;321:68V 696.	1b
24	Hassan AA, et al	Intraoperative magnesium sulphate decreases agitation and pain in patients undergoing functional endoscopic surgery: a randomised double-blind study. Eur J Anaesthesiol. 2017;34(10):658–64.	1b
25	Sutton AJ, et al	Non‐pharmacological interventions for preventing delirium in hospitalised non‐ICU patients. The Cochrane Database of Systematic Reviews. 2019;2019(4).	1a
26	Castelli A, et al.	A reorientation strategy for reducing delirium in the critically ill. Results of an interventional study. Minerva anestesiologica. 2012;78(9):1026.	1b
27	Jin Z, Hu J, et al.	Postoperative delirium: perioperative assessment, risk reduction, and management. British journal of anaesthesia. 2020.	1b
		Study on diagnosis for postoperative delirium
28	Schüle C, et al.	Screening for delirium after surgery: validation of the 4 A’s test (4AT) in the post‐anaesthesia care unit. Anaesthesia. 2019;74(10):1260–6.	2b
28	Young J, et al.	Delirium detection in older acute medical inpatients: a multicentre prospective comparative diagnostic test accuracy study of the 4AT and the confusion assessment method. BMC medicine. 2019;17(1):1–14.	2b
30	O’connor M, et al.	Diagnostic accuracy of the 4AT for delirium detection in older adults: systematic review and meta-analysis. Age and ageing. 2021;50(3):733–43.	1a
31	Association AP	Diagnostic and statistical manual of mental disorders (DSM-5®): American Psychiatric Pub; 2013.	2b
32	Dixon M.	Assessment and management of older patients with delirium in acute settings. Nursing older people. 2021;33(3).	2a
		Study on treatments for postoperative delirium
33	Hutton B, et al.	Antipsychotics for treatment of delirium in hospitalised non‐ICU patients. Cochrane Database of Systematic Reviews. 2018(6).	1a
34	Teunissen SC, et al.	Olanzapine versus haloperidol for treatment of delirium in patients with advanced cancer: a phase III randomized clinical trial. The oncologist. 2020;25(3):e570.	1b
35	Nanayakkara PW, et al	Efficacy and safety of haloperidol for in-hospital delirium prevention and treatment: a systematic review of current evidence. European journal of internal medicine. 2016;27:14–23.	2a
36	Manzanedo D, et al.	Dexmedetomidine for the treatment of hyperactive delirium refractory to haloperidol in nonintubated ICU patients: a nonrandomized controlled trial. Critical care medicine. 2016;44(7):1295–306.	1c
37	Mu W, et al.	Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit. Cochrane Database of Systematic Reviews. 2020(2).	1a
38	Naut ER, et al	Front-loaded diazepam versus lorazepam for treatment of alcohol withdrawal agitated delirium. The American journal of emergency medicine. 2021;44:415–8.	2b
39	Saczynski JS, et al.	Delirium in elderly people. The Lancet. 2014;383(9920):911–22.	1b
40	Borozdina A, et al	European Society of Anaesthesiology evidence-based and consensus-based guideline on postoperative delirium. European Journal of Anaesthesiology| EJA. 2017;34(4):192–214.	1a
41	Adults AGSEPoPDiO.	American Geriatrics Society abstracted clinical practice guideline for postoperative delirium in older adults. Journal of the American Geriatrics Society. 2015;63(1):142–50.	1a
42	Yeh T-C, et al.	Association of delirium response and safety of pharmacological interventions for the management and prevention of delirium: a network meta-analysis. JAMA psychiatry. 2019;76(5):526–35.	1a
43	Avasthi A, et al	Clinical practice guidelines for the management of delirium in elderly. Indian journal of psychiatry. 2018;60(Suppl 3):S329.	1a

Conclusion

Management of postoperative delirium includes specifying risks that were helpful for prevention, early diagnosis, and treatment. Early diagnosis is critical to trigger focused and effective treatment. The 4 ‘A’s Test tool is important for postoperative delirium diagnosis with good sensitivity and brief does not need a unique technique to perform. In the recovery room screening for POD Patients who are at risk of postoperative delirium was recommended. The first-line management for both hyperactive and hypoactive types of delirium is the nonpharmacological approach. Even if currently limited pharmacological options, it is recommended when non-pharmacological management fails. Based on currently available evidence, Dexmedetomidine is effective for the prevention of POD and is suggested as a treatment option for POD. It has also been suggested intraoperative administration of magnesium sulfate and postoperative IV acetaminophen reduces the incidence of postoperative agitation (see Figure 2).

Figure 2

Flow chart on perioperative management of post-operative delirium.